Journal list menu

Volume 159, Issue 1-2 p. 89-92
Full-length article
Free Access

Interaction of GRF with VIP receptors and stimulation of adenylate cyclase in rat and human intestinal epithelial membranes

Comparison with PHI and secretin

M. Laburthe

M. Laburthe

CNRS ERA 494, INSERM U.55, Equipe de Recherche sur le Mécanisme d'Action des Hormones et Neuropeptides Digestifs, Hôpital Saint-Antoine, 75571 Paris Cedex 12, France

Search for more papers by this author
B. Amiranoff

B. Amiranoff

CNRS ERA 494, INSERM U.55, Equipe de Recherche sur le Mécanisme d'Action des Hormones et Neuropeptides Digestifs, Hôpital Saint-Antoine, 75571 Paris Cedex 12, France

Search for more papers by this author
N. Boige

N. Boige

CNRS ERA 494, INSERM U.55, Equipe de Recherche sur le Mécanisme d'Action des Hormones et Neuropeptides Digestifs, Hôpital Saint-Antoine, 75571 Paris Cedex 12, France

Search for more papers by this author
C. Rouyer-Fessard

C. Rouyer-Fessard

CNRS ERA 494, INSERM U.55, Equipe de Recherche sur le Mécanisme d'Action des Hormones et Neuropeptides Digestifs, Hôpital Saint-Antoine, 75571 Paris Cedex 12, France

Search for more papers by this author
K. Tatemoto

K. Tatemoto

Department of Biochemistry II, Karolinska Institutet, S-104 01 Stockholm, Sweden

Search for more papers by this author
L. Moroder

L. Moroder

Max Planck Institut für Biochemie, Abteilung Peptidchemie, 8033 Martinsried, FRG

Search for more papers by this author
First published: August 08, 1983
Citations: 97

Abstract

GRF (10−8–10−5 M) is shown to inhibit competitively the binding of [125I]VIP to human and rat intestinal epithelial membranes. The affinity of GRF for VIP receptor is 700–800-times lower than that of VIP in both species. The order of affinity of different peptides is VIP > PHI > secretin > GRF in rat, and VIP > GRF > PHI > secretin in man. The important species specificity of VIP receptors in recognizing PHI and secretin does not occur in the case of GRF. GRF stimulates adenylate cyclase through its interaction with VIP receptors in rat and human membranes. However, while GRF behaves as a VIP agonist in human tissue, it is a partial agonist/antagonist of VIP in the rat.